Erratum: Indications to Hospital Admission and Isolation of Children with Possible or Defined Tuberculosis Systematic Review and Proposed Recommendations for Pediatric Patients Leaving in Developed Countries (Medicine (2015) 94:50 (e2045) DOI: 10.1097/MD.0000000000002045);Indications to hospital admission and isolation of children with possible or defined tuberculosis: Systematic review and proposed recommendations for pediatric patients leaving in developed countries

Medicine (United States)

Volumn 94, Issue 50, 2015, Pages

  Vecchio, Andrea Lo ^a   Bocchino, Marialuisa ^a   Lancella, Laura ^b   Gabiano, Clara ^c   Garazzino, Silvia ^c   Scotto, Riccardo ^a   Raffaldi, Irene ^c   Assante, Luca Rosario ^a   Villani, Alberto ^b   Esposito, Susanna ^d   Guarino, Alfredo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CHILD; CHILD HOSPITALIZATION; DEVELOPED COUNTRY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; IMMUNE DEFICIENCY; LUNG TUBERCULOSIS; MALNUTRITION; MULTIDRUG RESISTANT TUBERCULOSIS; PATIENT CARE; PATIENT REFERRAL; PNEUMONIA; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TERTIARY CARE CENTER; TUBERCULOSIS; AGE; ANTIBIOTIC RESISTANCE; COMPLICATION; FEMALE; GLASGOW COMA SCALE; HOSPITALIZATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; INFANT; INFECTION CONTROL; MALE; META ANALYSIS; NEWBORN; NUTRITIONAL DISORDER; ORGANIZATION AND MANAGEMENT; PATIENT ISOLATION; PRACTICE GUIDELINE; PRESCHOOL CHILD; RISK FACTOR;

AGE FACTORS; CHILD NUTRITION DISORDERS; CHILD, PRESCHOOL; DEVELOPED COUNTRIES; DRUG RESISTANCE, BACTERIAL; FEMALE; GLASGOW COMA SCALE; HIV INFECTIONS; HOSPITALIZATION; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INFANT, NEWBORN; INFECTION CONTROL; MALE; PATIENT ISOLATION; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; TUBERCULOSIS;

EID: 84952684987     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/01.md.0000480683.34568.fd     Document Type: Erratum

References (60)

1. World Health Organization. Global Tuberculosis Report 2014. Document WHO/HTM/TB/2014.08. Geneva: World Health Organization; 2014.
2. Fears R, Kaufmann S, Ter Meulen V, et al. EASAC Working Group. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control. Tuberculosis (Edinb). 2010;90:182-187.
3. Lönnroth K, Migliori GB, Abubakar I, et al. Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J. 2015;45:928-952.
4. Il Programma Nazionale per le Linee Guida (PNLG). Methodological Handbook-How to Produce, Disseminate and Update Clinical Practice Recommendations. http://www.pnlg.it/en-method. Accessed December 30. 2014.
5. Scottish Intercollegiate Guidelines Netwok (SIGN). Available at: http://www.sign. ac.uk/. Accessed December 30. 2014.
6. Guidelines for the planning and management of NIH Consensus Development Conferences Online. Bethesda, MD: National Institutes of Health, Office of the Director, Office of Medical Applications of Research; 1993. Updated October 2001.
7. National Institute for Health and Clinical Excellence. Tuberculosis. Clinical Diagnosis and Management of Tuberculosis, and Measures for Its Prevention and Control. guidance.nice.org.uk/cg 117. Accessed December 30, 2014.
8. World Health Organization. Guidance for National Tuberculosis Programs on the Management of Tuberculosis in Children. Geneva: World Health Organization; 2006.
9. Thomas JA, Laraque F, Munsiff S, et al. Hospitalizations for tuberculosis in New York City: how many could be avoided? Int J Tuberc Lung Dis. 2010;14:1603-1612.
10. Wu XR, Yin QQ, Jiao AX, et al. Pediatric tuberculosis at Beijing Children's hospital: 2002-2010. Pediatrics. 2012;130:e1433-e1440.
11. Faella FS, Pagliano P, Attanasio V, et al. Factors influencing the presentation and outcome of tuberculous meningitis in childhood. In Vivo. 2006;20:187-191.
12. Ramos JM, Reyes F, Tesfamariam A. Childhood and adult tuberculosis in a rural hospital in Southeast Ethiopia: a ten-year retrospective study. BMC Public Health. 2010;10:215.
13. Seddon JA, Visser DH, Bartens M, et al. Impact of drug resistance on clinical outcome in children with tuberculous meningitis. Pediatr Infect Dis J. 2012;31:711-716.
14. Thampi N, Stephens D, Rea E, et al. Unexplained deterioration during antituberculous therapy in children and adolescents: clinical presentation and risk factors. Pediatr Infect Dis J. 2012;31:129-133.
15. Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011;66(Suppl 2):1-23.
16. Bradley JS, Byington CL, Shah SS, et al. Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53:617-630.
17. Esposito S, Cohen R, Domingo JD, et al. Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat? Pediatr Infect Dis J. 2012;31:e78-e85.
18. Khan AE, Starke JR. Diagnosis of tuberculosis in children: increased need for better methods. Emerg Infect Dis. 1995;1:115-123.
19. Peng W, Yang J, Liu E. Analysis of 170 cases of congenital TB reported in the literature between 1946 and 2009. Pediatr Pulmonol. 2011;46:1215-1224.
20. Marais BJ, Gie RP, Hesseling AC, et al. A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Pediatrics. 2006;118:e1350-e1359.
21. van den Bos F, Terken M, Ypma L, et al. Tuberculous meningitis and miliary tuberculosis in young children. Trop Med Int Health. 2004;9:309-313.
22. Madhi SA, Gray GE, Huebner RE, et al. Correlation between CD4 + lymphocyte counts, concurrent antigen skin test and tuberculin skin test reactivity in human immunodeficiency virus type 1-infected and -uninfected children with tuberculosis. Pediatr Infect Dis J. 1999;18:800-805.
23. Jensen J, Álvaro-Meca A, Micheloud D, et al. Reduction in mycobacterial disease among HIV-infected children in the highly active antiretroviral therapy era (1997-2008). Pediatr Infect Dis J. 2012;31:278-283.
24. Hesseling AC, Cotton MF, Jennings T, et al. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis. 2009;48:108-114.
25. van Well GT, Paes BF, Terwee CB, et al. Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the western cape of South Africa. Pediatrics. 2009;123:e1-e8.
26. Vecino R, Santiago B, Baquero-Artigao F, et al. Tuberculosis in pediatric solid organ and hematopoietic stem cell transplant recipients. Pediatr Infect Dis J. 2012;31:774-777.
27. Centers for Disease Control and Prevention (CDC). Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep. 2005;54:1-47.
28. Humphreys H. Control and prevention of heathcare-associated tuberculosis: the role of respiratory isolation and personal respiratory protection. J Hosp Infect. 2007;66:1-5.
29. Wong KS, Huang YC, Lai SH, et al. Validity of symptoms and radiographic features in predicting positive AFB smears in adolescents with tuberculosis. Int J Tuberc Lung Dis. 2010;14:155-159.
30. Wang CS, Chen HC, Chong IW, et al. Predictors for identifying the most infectious pulmonary tuberculosis patient. J Formos Med Assoc. 2008;107:13-20.
31. Kim SJ, Bai GH, Lee H, et al. Transmission of Mycobacterium tuberculosis among high school students in Korea. Int J Tuberc Lung Dis. 2001;5:824-830.
32. Christie CD, Constantinou P, Marx ML, et al. Low risk for tuberculosis in a regional pediatric hospital: nine-year study of community rates and the mandatory employee tuberculin skin-test program. Infect Control Hosp Epidemiol. 1998;19:168-174.
33. Muñoz FM, Ong LT, Seavy D, et al. Tuberculosis among adult visitors of children with suspected tuberculosis and employees at a children's hospital. Infect Control Hosp Epidemiol. 2002;23:568-572.
34. Cruz AT, Medina D, Whaley EM, et al. Tuberculosis among families of children with suspected tuberculosis and employees at a children's hospital. Infect Control Hosp Epidemiol. 2011;32:188-190.
35. Crockett M, King SM, Kitai I, et al. Nosocomial transmission of congenital tuberculosis in a neonatal intensive care unit. Clin Infect Dis. 2004;39:1719-1723.
36. Mouchet F, Hansen V, Van Herreweghe I, et al. Tuberculosis in a healthcare workers caring for a congenitally infected infant. Infect Control Hosp Epidemiol. 2004;25:1062-1066.
37. Curtis AB, Ridzon R, Vogel R, et al. Extensive transmission of Mycobacterium tuberculosis from a child. N Engl J Med. 1999;341:1491-1495.
38. Rabalais G, Adams G, Stover B. PPD skin test conversion in healthcare workers after exposure to Mycobacterium tuberculosis infection in infants. Lancet. 1991;338:826.
39. Reynolds DL, Gillis F, Kitai I, et al. Transmission of Mycobacterium tuberculosis from an infant. Int J Tuberc Lung Dis. 2006;10:1051-1056.
40. Centers for Disease Control and Prevention (CDC). TB elimination. Respiratory Protection in Health-care Settings. 2010; www.cdc.gov/tb. Accessed December 30, 2014.
41. Matlow A, Robb M, Goldman C. Infection control and paediatric tuberculosis: a practical guide for the practicing paediatrician. Paediatr Child Health. 2003;8:624-626.
42. Sutton PM, Nicas M, Harrison RJ. Tuberculosis isolation: comparison of written procedures and actual practices in three California hospitals. Infect Control Hosp Epidemiol. 2000;21:28-32.
43. Tokars JI, McKinley GF, Otten J, et al. Use and efficacy of tuberculosis infection control practices at hospitals with previous outbreaks of multidrug-resistant tuberculosis. Infect Control Hosp Epidemiol. 2001;22:449-455.
44. Kellerman SE, Saiman L, San Gabriel P, et al. Observational study of the use of infection control interventions for Mycobacterium tuberculosis in pediatric facilities. Pediatr Infect Dis J. 2001;20:566-570.
45. Menzies D. Effect of treatment on contagiousness of patients with active pulmonary tuberculosis. Infect Control Hosp Epidemiol. 1997;18:582-586.
46. Telzak EE, Fazal BA, Pollard CL, et al. Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis. Clin Infect Dis. 1997;25:666-670.
47. Horne DJ. How soon can smear positive TB patients be released from inpatient isolation? Infect Control Hosp Epidemiol. 2010;31:78-84.
48. Fennelly KP, Martyny JW, Fulton KE, et al. Cough generated aerosols of Mycobacterium tuberculosis: a new method to study infectiousness. Am J Respir Crit Care Med. 2004;169:604-609.
49. Long R, Bochar K, Chomyc S, et al. Relative versus absolute non contagiousness of respiratory tuberculosis on treatment. Infect Control Hosp Epidemiol. 2003;24:831-838.
50. Ritchie SR, Harrison AC, Vaughan RH, et al. New recommendations for duration of respiratory isolation based on time to detect Mycobacterium tuberculosis in liquid culture. Eur Respir J. 2007;30:501-507.
51. Hellyer TJ, Fletcher TW, Bates JH, et al. Strand displacement amplification and the polymerase chain reaction for monitoring response to treatment in patients with pulmonary tuberculosis. J Infect Dis. 1996;173:934-941.
52. Hellyer TJ, DesJardin LE, Teixeira L, et al. Detection of viable Mycobacterium tuberculosis by reverse transcriptase-strand displacement amplification of mRNA. J Clin Microbiol. 1999;37:518-523.
53. Desjardin LE, Perkins MD, Wolski K, et al. Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy. Am J Respir Crit Care Med. 1999;160:203-210.
54. Li L, Mahan CS, Palaci M, et al. Sputum Mycobacterium tuberculosis mRNA as a marker of bacteriologic clearance in response to antituberculosis therapy. J Clin Microbiol. 2010;48:46-51.
55. Craft DW, Jones MC, Blanchet CN, et al. Value of examining three acid-fast bacillus sputum smears for removal of patients suspected of having tuberculosis from the "airborne precautions" category. J Clin Microbiol. 2000;38:4285-4287.
56. Siddiqui AH, Perl TM, Conlon M, et al. Preventing nosocomial transmission of pulmonary tuberculosis: when may isolation be discontinued for patients with suspected tuberculosis? Infect Control Hosp Epidemiol. 2002;23:141-144.
57. Mixides G, Shende V, Teeter LD, et al. Number of negative acidfast smears needed to adequately assess infectivity of patients with pulmonary tuberculosis. Chest. 2005;128:108-115.
58. Janssen S, Padanilam X, Louw R, et al. How many sputum culture results do we need to monitor multi-drug resistant tuberculosis (MDR-TB) patients during treatment? J Clin Microbiol. 2013;51:644.
59. Laserson KF, Thorpe LE, Leimane V, et al. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2005;9:640-645.
60. American Academy of Pediatrics. Tuberculosis. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, eds. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th ed Elk Grove Village, IL: American Academy of Pediatrics; 2012:736-759.